XML 39 R29.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY-BASED COMPENSATION - Narrative (Details) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Dec. 31, 2020
Dec. 31, 2019
Jul. 19, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding 1,587,472 322,233 1,563,972 166,233  
Number of stock options granted (shares) 68,500 182,000      
Fair value $ 0.1 $ 0.1      
Unrecognized compensation cost, options $ 1.1 $ 0.4      
Unrecognized compensation cost, recognition period 2 years 8 months 12 days        
Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options, contractual term 10 years        
Minimum | Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period 1 year        
Maximum | Employee Stock Option          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting period 4 years        
2015 Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Shares remaining available for grant of stock awards (shares) 1,037,190        
Flex Pharma          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares outstanding 34,385       90,279